BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6203218)

  • 1. Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies.
    Webster RG; Brown LE; Laver WG
    Virology; 1984 May; 135(1):30-42. PubMed ID: 6203218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase.
    Air GM; Els MC; Brown LE; Laver WG; Webster RG
    Virology; 1985 Sep; 145(2):237-48. PubMed ID: 2411049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic structure and variation in an influenza virus N9 neuraminidase.
    Webster RG; Air GM; Metzger DW; Colman PM; Varghese JN; Baker AT; Laver WG
    J Virol; 1987 Sep; 61(9):2910-6. PubMed ID: 3612957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence of the neuraminidase gene of influenza virus A/Tokyo/3/67 and previously uncharacterized monoclonal variants.
    Lentz MR; Air GM; Laver WG; Webster RG
    Virology; 1984 May; 135(1):257-65. PubMed ID: 6203216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuraminidases of the virulent and avirulent A/Chicken/Pennsylvania/83 (H5N2) influenza A viruses: sequence and antigenic analyses.
    Deshpande KL; Naeve CW; Webster RG
    Virology; 1985 Nov; 147(1):49-60. PubMed ID: 2414922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase.
    Air GM; Laver WG; Webster RG
    J Virol; 1990 Dec; 64(12):5797-803. PubMed ID: 1700825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of influenza A virus neuraminidase using lectin test and monoclonal antibodies.
    Varecková E; Lyubovtseva OV; Russ G; Styk B; Zakstelskaya LYa ; Yakhno MA
    Acta Virol; 1986 Jul; 30(4):281-8. PubMed ID: 2876609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic properties of the A/H3N2 influenza neuraminidases: influence of antigenic variations.
    Deshairs C; Kessler N; Aymard M; Quash GA
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():409-18. PubMed ID: 3950578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of H2 influenza virus hemagglutinin with monoclonal antibodies: influence of receptor specificity.
    Yamada A; Brown LE; Webster RG
    Virology; 1984 Oct; 138(2):276-86. PubMed ID: 6208682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antigenic structure of the influenza B virus hemagglutinin: operational and topological mapping with monoclonal antibodies.
    Berton MT; Webster RG
    Virology; 1985 Jun; 143(2):583-94. PubMed ID: 2414911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A topographic map of the enzyme active center and antigenic sites on the neuraminidase of influenza virus A/Tokyo/3/67 (H2N2).
    Jackson DC; Webster RG
    Virology; 1982 Nov; 123(1):69-77. PubMed ID: 6183827
    [No Abstract]   [Full Text] [Related]  

  • 12. [The nature of amino acid substitution in antigenic drift of hemagglutinin N3 and neuraminidase N2 from the influenza virus].
    Eroshkin AM; Kulichkov VA
    Mol Biol (Mosk); 1986; 20(2):546-57. PubMed ID: 2422540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 18-amino acid deletion in an influenza neuraminidase.
    Els MC; Air GM; Murti KG; Webster RG; Laver WG
    Virology; 1985 Apr; 142(2):241-7. PubMed ID: 4060573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against lethal influenza with neuraminidase.
    Webster RG; Reay PA; Laver WG
    Virology; 1988 May; 164(1):230-7. PubMed ID: 2452514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenic specificity of the neuraminidases of epidemic strains of influenza A/H3N2 viruses circulating in the USSR 1983-1985].
    Liubovtseva OV; Iakhno MA; Zakstel'skaia LIa
    Vopr Virusol; 1987; 32(3):283-5. PubMed ID: 2445104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological and protective properties of immune sera directed to the influenza virus neuraminidase.
    Halbherr SJ; Ludersdorfer TH; Ricklin M; Locher S; Berger Rentsch M; Summerfield A; Zimmer G
    J Virol; 2015 Feb; 89(3):1550-63. PubMed ID: 25392225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioimmunological analysis of the neuraminidase of influenza virus subtype N2].
    Gitel'man AK; Zakomyrdin IuA; Kharitonenkov IG
    Vopr Virusol; 1983; 28(5):556-61. PubMed ID: 6659471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influenza viruses which preconditioned the epidemic rise in Russia in 2002-2003. A resumed circulation of influenza viruses similar to V/Victoria/2/87].
    Ivanova VT; Burtseva EI; Slepushkin AN; Oskerko TA; Zagorskaia IuV; Shevchenko ES; Mashkova SA; Feodoritova EL
    Vopr Virusol; 2004; 49(3):12-7. PubMed ID: 15188649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus.
    Kida H; Webster RG; Yanagawa R
    Arch Virol; 1983; 76(2):91-9. PubMed ID: 6191738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
    Wan H; Qi L; Gao J; Couzens LK; Jiang L; Gao Y; Sheng ZM; Fong S; Hahn M; Khurana S; Taubenberger JK; Eichelberger MC
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.